UV Innovators™ announces Dr. David J. Weber Joins Scientific Advisory Board

Renowned infectious disease epidemiologist joins an ultraviolet disinfection team in their creation of solutions to fight deadly pathogens.

June 18, 2020 – Research Triangle, North Carolina   -- UV Innovators, LLC., an ultraviolet technology company, announced today that David J. Weber, M.D., M.P.H., has joined its scientific advisory board.  Dr. Weber, a preeminent global expert in infection prevention,  serves as Professor of Medicine and Pediatrics at the University of North Carolina (UNC) School of Medicine, Professor of Epidemiology at the UNC Gillings School of Global Public Health, Associate Chief Medical Officer for UNC Health Care, and Medical Director of the Department of Infection Prevention for the UNC Medical Center.  Since the first days of the outbreak, he has been working with the CDC, FDA, and other local health departments to understand the coronavirus (COVID-19) and its mechanism for community spreading. 

“The global public health and financial impact of COVID-19 have put a strain on resources and created a substantial need to find therapeutic and preventative solutions quickly," stated Dr. Weber. "People are coming to understand the necessity of social distancing, wearing a face mask, having good hand hygiene and effective surface disinfection solutions," Weber added.

"Dr. Weber is on the frontlines of infection prevention, especially concerning antibiotic-resistant pathogens, disinfection methodology, and outbreak investigations. He has a personal goal to eliminate healthcare-associated infections which is aligned with our company’s mission,” stated Dr. Nicholas Medendorp, Jr., CEO of UV Innovators. “A study in the New England Journal of Medicine has identified that SARS-CoV-2, the virus that causes COVID-19, can survive and remain contagious on surfaces for many hours. There must be further expansion into UVC disinfection as an effective means of combating this deadly virus,” states Dr. Medendorp.

The UV Innovators team designs and develops ultraviolet technology, conducts pathogen inactivation testing, and produces industrial-grade UVC disinfection solutions to all industries in need of infection control and prevention.  To learn more about how SARS-CoV-2 can live on surfaces for up to 8 hours, review this article in the New England Journal of Medicine (382; 2020, 16, 1564-1567).

About UV Innovators, LLC

UV Innovators, LLC uses its extensive illumination and medical device intellectual property to deliver disinfection solutions across a vast set of markets -- from private aviation and clinical care facilities, to healthy office buildings and schools.  UV Innovators is set to redefine the standard of surface disinfection with the commercialization of its portable UVC product, which delivers the effective germ deactivating power of disinfection towers with the speed and mobility of a handheld device. For more information, visit www.uvinnovators.com or contact us at info@uvinnovators.com.

About Dr. Weber

Dr. Weber is a world-renowned leader in the treatment of infectious diseases.  He is the  Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine and Pediatrics at the University of North Carolina (UNC) School of Medicine and Professor of Epidemiology in the UNC Gillings School of Global Public Health, Associate Chief Medical Officer for UNC Medical Center and serves as Medical Director, Department of Infection Prevention, UNC Medical Center.  Additionally, Dr. Weber is the Associate Director of the North Carolina Statewide Infection Control Program (SPICE).  Dr. Weber holds his M.D. from the University of California, and his M.P.H., School of Public Health, Harvard University. Dr. Weber has been Board certified in Internal Medicine, Infectious Diseases, Critical Care Medicine and Preventive Medicine.  Dr. Weber is cited as an author in >440 scientific publications by PubMed. 

Forward-looking Statements

Except for historical information, all the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially to include risks associated with technology development process; reliance on key personnel; the early stage of our business; competition; and other risks described in other Company press releases and presentations. UV Innovators assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

 

Media Contact

Kathleen Regan

919-302-5145

kregan@uvinnovators.com